Industry Research Reports
Home > Reports > Service & Software > Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-03-11
Pages: 129 Pages
Report ld: 4642182
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Cell and Gene Therapy Supply Chain Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell and Gene Therapy Supply Chain Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Cell and Gene Therapy Supply Chain Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Cell and Gene Therapy Supply Chain Solution include Cencora, Inc（World Courier）, QuickStat, Associated Couriers, LLC, Central Pharma, POLAR EXPRES, Biocair, time:matters, Mercury Business Services, Cardinal Health, CRYOPDP, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Supply Chain Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cell and Gene Therapy Supply Chain Solution by region & country, by Type, and by Application.
The Cell and Gene Therapy Supply Chain Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Supply Chain Solution.
MARKET SEGMENTATION
By Company
- Cencora, Inc（World Courier）
- QuickStat
- Associated Couriers, LLC
- Central Pharma
- POLAR EXPRES
- Biocair
- time:matters
- Mercury Business Services
- Cardinal Health
- CRYOPDP
- Cryoport
- NMDP BioTherapies
- McKesson
- Excel Courier
- Almac
- BEAM Logistics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Courier Company Provided
- Hosted Logistics Company Provided
Segment by Application
- Biotech and Pharmaceutical Companies
- Hospitals
- Research Organizations
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cell and Gene Therapy Supply Chain Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cell and Gene Therapy Supply Chain Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cell and Gene Therapy Supply Chain Solution in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Cell and Gene Therapy Supply Chain Solution Product Introduction
1.2 Global Cell and Gene Therapy Supply Chain Solution Market Size Forecast (2020-2031)
1.3 Cell and Gene Therapy Supply Chain Solution Market Trends & Drivers
1.3.1 Cell and Gene Therapy Supply Chain Solution Industry Trends
1.3.2 Cell and Gene Therapy Supply Chain Solution Market Drivers & Opportunity
1.3.3 Cell and Gene Therapy Supply Chain Solution Market Challenges
1.3.4 Cell and Gene Therapy Supply Chain Solution Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cell and Gene Therapy Supply Chain Solution Players Revenue Ranking (2024)
2.2 Global Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025)
2.3 Key Companies Cell and Gene Therapy Supply Chain Solution Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cell and Gene Therapy Supply Chain Solution Product Offered
2.5 Key Companies Time to Begin Mass Production of Cell and Gene Therapy Supply Chain Solution
2.6 Cell and Gene Therapy Supply Chain Solution Market Competitive Analysis
2.6.1 Cell and Gene Therapy Supply Chain Solution Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Cell and Gene Therapy Supply Chain Solution Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain Solution as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Courier Company Provided
3.1.2 Hosted Logistics Company Provided
3.2 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Type
3.2.1 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Cell and Gene Therapy Supply Chain Solution Sales Value, by Type (2020-2031)
3.2.3 Global Cell and Gene Therapy Supply Chain Solution Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotech and Pharmaceutical Companies
4.1.2 Hospitals
4.1.3 Research Organizations
4.1.4 Other
4.2 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Application
4.2.1 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Cell and Gene Therapy Supply Chain Solution Sales Value, by Application (2020-2031)
4.2.3 Global Cell and Gene Therapy Supply Chain Solution Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region
5.1.1 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (2020-2025)
5.1.3 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (2026-2031)
5.1.4 Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
5.2.2 North America Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
5.3.2 Europe Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
5.4.2 Asia Pacific Cell and Gene Therapy Supply Chain Solution Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
5.5.2 South America Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
5.6.2 Middle East & Africa Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cell and Gene Therapy Supply Chain Solution Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.3 United States
6.3.1 United States Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.3.2 United States Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.4.2 Europe Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.5.2 China Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.5.3 China Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.6.2 Japan Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.7.2 South Korea Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.8.2 Southeast Asia Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Cell and Gene Therapy Supply Chain Solution Sales Value, 2020-2031
6.9.2 India Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
6.9.3 India Cell and Gene Therapy Supply Chain Solution Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Cencora, Inc（World Courier）
7.1.1 Cencora, Inc（World Courier） Profile
7.1.2 Cencora, Inc（World Courier） Main Business
7.1.3 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.1.4 Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.1.5 Cencora, Inc（World Courier） Recent Developments
7.2 QuickStat
7.2.1 QuickStat Profile
7.2.2 QuickStat Main Business
7.2.3 QuickStat Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.2.4 QuickStat Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.2.5 QuickStat Recent Developments
7.3 Associated Couriers, LLC
7.3.1 Associated Couriers, LLC Profile
7.3.2 Associated Couriers, LLC Main Business
7.3.3 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.3.4 Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.3.5 Associated Couriers, LLC Recent Developments
7.4 Central Pharma
7.4.1 Central Pharma Profile
7.4.2 Central Pharma Main Business
7.4.3 Central Pharma Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.4.4 Central Pharma Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.4.5 Central Pharma Recent Developments
7.5 POLAR EXPRES
7.5.1 POLAR EXPRES Profile
7.5.2 POLAR EXPRES Main Business
7.5.3 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.5.4 POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.5.5 POLAR EXPRES Recent Developments
7.6 Biocair
7.6.1 Biocair Profile
7.6.2 Biocair Main Business
7.6.3 Biocair Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.6.4 Biocair Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.6.5 Biocair Recent Developments
7.7 time:matters
7.7.1 time:matters Profile
7.7.2 time:matters Main Business
7.7.3 time:matters Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.7.4 time:matters Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.7.5 time:matters Recent Developments
7.8 Mercury Business Services
7.8.1 Mercury Business Services Profile
7.8.2 Mercury Business Services Main Business
7.8.3 Mercury Business Services Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.8.4 Mercury Business Services Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.8.5 Mercury Business Services Recent Developments
7.9 Cardinal Health
7.9.1 Cardinal Health Profile
7.9.2 Cardinal Health Main Business
7.9.3 Cardinal Health Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.9.4 Cardinal Health Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.9.5 Cardinal Health Recent Developments
7.10 CRYOPDP
7.10.1 CRYOPDP Profile
7.10.2 CRYOPDP Main Business
7.10.3 CRYOPDP Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.10.4 CRYOPDP Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.10.5 CRYOPDP Recent Developments
7.11 Cryoport
7.11.1 Cryoport Profile
7.11.2 Cryoport Main Business
7.11.3 Cryoport Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.11.4 Cryoport Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.11.5 Cryoport Recent Developments
7.12 NMDP BioTherapies
7.12.1 NMDP BioTherapies Profile
7.12.2 NMDP BioTherapies Main Business
7.12.3 NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.12.4 NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.12.5 NMDP BioTherapies Recent Developments
7.13 McKesson
7.13.1 McKesson Profile
7.13.2 McKesson Main Business
7.13.3 McKesson Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.13.4 McKesson Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.13.5 McKesson Recent Developments
7.14 Excel Courier
7.14.1 Excel Courier Profile
7.14.2 Excel Courier Main Business
7.14.3 Excel Courier Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.14.4 Excel Courier Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.14.5 Excel Courier Recent Developments
7.15 Almac
7.15.1 Almac Profile
7.15.2 Almac Main Business
7.15.3 Almac Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.15.4 Almac Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.15.5 Almac Recent Developments
7.16 BEAM Logistics
7.16.1 BEAM Logistics Profile
7.16.2 BEAM Logistics Main Business
7.16.3 BEAM Logistics Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
7.16.4 BEAM Logistics Cell and Gene Therapy Supply Chain Solution Revenue (US$ Million) & (2020-2025)
7.16.5 BEAM Logistics Recent Developments
8 Industry Chain Analysis
8.1 Cell and Gene Therapy Supply Chain Solution Industrial Chain
8.2 Cell and Gene Therapy Supply Chain Solution Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cell and Gene Therapy Supply Chain Solution Sales Model
8.5.2 Sales Channel
8.5.3 Cell and Gene Therapy Supply Chain Solution Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Cell and Gene Therapy Supply Chain Solution Market Trends
Table 2. Cell and Gene Therapy Supply Chain Solution Market Drivers & Opportunity
Table 3. Cell and Gene Therapy Supply Chain Solution Market Challenges
Table 4. Cell and Gene Therapy Supply Chain Solution Market Restraints
Table 5. Global Cell and Gene Therapy Supply Chain Solution Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Cell and Gene Therapy Supply Chain Solution Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Cell and Gene Therapy Supply Chain Solution Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cell and Gene Therapy Supply Chain Solution Product Type
Table 9. Key Companies Time to Begin Mass Production of Cell and Gene Therapy Supply Chain Solution
Table 10. Global Cell and Gene Therapy Supply Chain Solution Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Supply Chain Solution as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Cell and Gene Therapy Supply Chain Solution Sales Market Share in Value by Type (2020-2025)
Table 17. Global Cell and Gene Therapy Supply Chain Solution Sales Market Share in Value by Type (2026-2031)
Table 18. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Cell and Gene Therapy Supply Chain Solution Sales Market Share in Value by Application (2020-2025)
Table 22. Global Cell and Gene Therapy Supply Chain Solution Sales Market Share in Value by Application (2026-2031)
Table 23. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (2020-2025) & (%)
Table 27. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Cell and Gene Therapy Supply Chain Solution Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Cell and Gene Therapy Supply Chain Solution Sales Value, (2026-2031) & (US$ Million)
Table 31. Cencora, Inc（World Courier） Basic Information List
Table 32. Cencora, Inc（World Courier） Description and Business Overview
Table 33. Cencora, Inc（World Courier） Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Cencora, Inc（World Courier） (2020-2025)
Table 35. Cencora, Inc（World Courier） Recent Developments
Table 36. QuickStat Basic Information List
Table 37. QuickStat Description and Business Overview
Table 38. QuickStat Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of QuickStat (2020-2025)
Table 40. QuickStat Recent Developments
Table 41. Associated Couriers, LLC Basic Information List
Table 42. Associated Couriers, LLC Description and Business Overview
Table 43. Associated Couriers, LLC Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Associated Couriers, LLC (2020-2025)
Table 45. Associated Couriers, LLC Recent Developments
Table 46. Central Pharma Basic Information List
Table 47. Central Pharma Description and Business Overview
Table 48. Central Pharma Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Central Pharma (2020-2025)
Table 50. Central Pharma Recent Developments
Table 51. POLAR EXPRES Basic Information List
Table 52. POLAR EXPRES Description and Business Overview
Table 53. POLAR EXPRES Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of POLAR EXPRES (2020-2025)
Table 55. POLAR EXPRES Recent Developments
Table 56. Biocair Basic Information List
Table 57. Biocair Description and Business Overview
Table 58. Biocair Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Biocair (2020-2025)
Table 60. Biocair Recent Developments
Table 61. time:matters Basic Information List
Table 62. time:matters Description and Business Overview
Table 63. time:matters Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of time:matters (2020-2025)
Table 65. time:matters Recent Developments
Table 66. Mercury Business Services Basic Information List
Table 67. Mercury Business Services Description and Business Overview
Table 68. Mercury Business Services Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Mercury Business Services (2020-2025)
Table 70. Mercury Business Services Recent Developments
Table 71. Cardinal Health Basic Information List
Table 72. Cardinal Health Description and Business Overview
Table 73. Cardinal Health Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Cardinal Health (2020-2025)
Table 75. Cardinal Health Recent Developments
Table 76. CRYOPDP Basic Information List
Table 77. CRYOPDP Description and Business Overview
Table 78. CRYOPDP Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of CRYOPDP (2020-2025)
Table 80. CRYOPDP Recent Developments
Table 81. Cryoport Basic Information List
Table 82. Cryoport Description and Business Overview
Table 83. Cryoport Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Cryoport (2020-2025)
Table 85. Cryoport Recent Developments
Table 86. NMDP BioTherapies Basic Information List
Table 87. NMDP BioTherapies Description and Business Overview
Table 88. NMDP BioTherapies Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of NMDP BioTherapies (2020-2025)
Table 90. NMDP BioTherapies Recent Developments
Table 91. McKesson Basic Information List
Table 92. McKesson Description and Business Overview
Table 93. McKesson Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of McKesson (2020-2025)
Table 95. McKesson Recent Developments
Table 96. Excel Courier Basic Information List
Table 97. Excel Courier Description and Business Overview
Table 98. Excel Courier Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Excel Courier (2020-2025)
Table 100. Excel Courier Recent Developments
Table 101. Almac Basic Information List
Table 102. Almac Description and Business Overview
Table 103. Almac Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 104. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of Almac (2020-2025)
Table 105. Almac Recent Developments
Table 106. BEAM Logistics Basic Information List
Table 107. BEAM Logistics Description and Business Overview
Table 108. BEAM Logistics Cell and Gene Therapy Supply Chain Solution Products, Services and Solutions
Table 109. Revenue (US$ Million) in Cell and Gene Therapy Supply Chain Solution Business of BEAM Logistics (2020-2025)
Table 110. BEAM Logistics Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Cell and Gene Therapy Supply Chain Solution Downstream Customers
Table 114. Cell and Gene Therapy Supply Chain Solution Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy Supply Chain Solution Product Picture
Figure 2. Global Cell and Gene Therapy Supply Chain Solution Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Cell and Gene Therapy Supply Chain Solution Sales Value (2020-2031) & (US$ Million)
Figure 4. Cell and Gene Therapy Supply Chain Solution Report Years Considered
Figure 5. Global Cell and Gene Therapy Supply Chain Solution Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cell and Gene Therapy Supply Chain Solution Revenue in 2024
Figure 7. Cell and Gene Therapy Supply Chain Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Courier Company Provided Picture
Figure 9. Hosted Logistics Company Provided Picture
Figure 10. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Cell and Gene Therapy Supply Chain Solution Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Biotech and Pharmaceutical Companies
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Research Organizations
Figure 15. Product Picture of Other
Figure 16. Global Cell and Gene Therapy Supply Chain Solution Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Cell and Gene Therapy Supply Chain Solution Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America Cell and Gene Therapy Supply Chain Solution Sales Value (2020-2031) & (US$ Million)
Figure 19. North America Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific Cell and Gene Therapy Supply Chain Solution Sales Value by Region (%), 2024 VS 2031
Figure 24. South America Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa Cell and Gene Therapy Supply Chain Solution Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions Cell and Gene Therapy Supply Chain Solution Sales Value (%), (2020-2031)
Figure 29. United States Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 31. United States Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 35. China Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 36. China Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 37. China Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 47. India Cell and Gene Therapy Supply Chain Solution Sales Value, (2020-2031) & (US$ Million)
Figure 48. India Cell and Gene Therapy Supply Chain Solution Sales Value by Type (%), 2024 VS 2031
Figure 49. India Cell and Gene Therapy Supply Chain Solution Sales Value by Application (%), 2024 VS 2031
Figure 50. Cell and Gene Therapy Supply Chain Solution Industrial Chain
Figure 51. Cell and Gene Therapy Supply Chain Solution Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cell and Gene Therapy Supply Chain Solution market?
The top companies in the global Cell and Gene Therapy Supply Chain Solution market are Cencora, Inc（World Courier）、QuickStat、Associated Couriers, LLC.
Related Reports
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 146
USD 4900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 107
USD 4250.00
(Single User License)
Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 130
USD 3950.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2026
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 130
USD 2900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 105
USD 4250.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 155
USD 4900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 91
USD 2900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-12
Pages: 93
USD 2900.00
(Single User License)
Global and United States Cell and Gene Therapy Supply Chain Solution Market Report & Forecast 2024-2030
The global Cell and Gene Therapy Supply Chain Solution revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-12
Pages: 128
USD 4350.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Insights, Forecast to 2030
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-07-12
Pages: 156
USD 4900.00
(Single User License)
Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 146
USD 4900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 107
USD 4250.00 (Single User License)Cell and Gene Therapy Supply Chain Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell and Gene Therapy Supply Chain Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 130
USD 3950.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2026
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 130
USD 2900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell and Gene Therapy Supply Chain Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 105
USD 4250.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 155
USD 4900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2025
The global market for Cell and Gene Therapy Supply Chain Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 91
USD 2900.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Research Report 2024
The global Cell and Gene Therapy Supply Chain Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-12
Pages: 93
USD 2900.00 (Single User License)Global and United States Cell and Gene Therapy Supply Chain Solution Market Report & Forecast 2024-2030
The global Cell and Gene Therapy Supply Chain Solution revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-12
Pages: 128
USD 4350.00 (Single User License)Global Cell and Gene Therapy Supply Chain Solution Market Insights, Forecast to 2030
The global Cell and Gene Therapy Supply Chain Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-07-12
Pages: 156
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now